Niagen Bioscience Files 8-K for Material Agreement
Ticker: NAGE · Form: 8-K · Filed: Jul 29, 2025 · CIK: 1386570
| Field | Detail |
|---|---|
| Company | Niagen Bioscience, Inc. (NAGE) |
| Form Type | 8-K |
| Filed Date | Jul 29, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-filing
Related Tickers: CDXC
TL;DR
Niagen Bioscience (CDXC) signed a material definitive agreement on 7/25, filed 8-K on 7/29.
AI Summary
Niagen Bioscience, Inc. filed an 8-K on July 29, 2025, reporting a material definitive agreement entered into on July 25, 2025. The filing also includes financial statements and exhibits. The company was formerly known as ChromaDex Corp. and Cody Resources, Inc.
Why It Matters
This filing indicates a significant new agreement for Niagen Bioscience, Inc., which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood.
Key Players & Entities
- Niagen Bioscience, Inc. (company) — Registrant
- ChromaDex Corp. (company) — Former company name
- Cody Resources, Inc. (company) — Former company name
- July 25, 2025 (date) — Date of material definitive agreement
- July 29, 2025 (date) — Filing date of the 8-K
FAQ
What is the nature of the material definitive agreement?
The filing does not specify the details of the material definitive agreement, only that one was entered into on July 25, 2025.
When was the 8-K filing submitted?
The 8-K filing was submitted on July 29, 2025.
What were Niagen Bioscience's former company names?
Niagen Bioscience, Inc. was formerly known as ChromaDex Corp. and Cody Resources, Inc.
What is the company's principal executive office address?
The principal executive offices are located at 10900 Wilshire Blvd., Suite 600, Los Angeles, California 90024.
What is the company's IRS Employer Identification Number?
The IRS Employer Identification Number for Niagen Bioscience, Inc. is 26-2940963.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 29, 2025 regarding Niagen Bioscience, Inc. (NAGE).